Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverEMBC
HealthcareNMSUSD

Embecta Corp.

$00123456789.0012345678900123456789+2.3%
52w low $2.77$14.91 52w high
Market data · updated 5h ago
Market data
Market cap
$204.09M
52w range
$2.77 - $14.91
Beta
0.81
Sector
Healthcare
Data quality
75/100
Valuation
P/E ratio
1.8x
fair value estimate
$7.57
Margin of safety
+30.7%
Forward P/E
2.0x
Dividend yield
14.15%
Quality & efficiency
Moat score
37/100
Profit margin
10.7%
Growth & analysts
Revenue growth
-14.4%
Analyst target
$4.00
Target upside
-30.9%
Analysts
2
Run the 10-point checklist before you buy How these numbers are made

About Embecta Corp.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Valuation

ValueGrowthProfitHealthIncome64QUALITY
Overall Rating
72
High quality
High quality

Derived from filed metrics · High confidence (75% of the inputs available)

Moat Score37
Fair value estimate
$7.57+30.7% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$204.09M
P/E Ratio
1.8
Dividend Yield
14.15%
Revenue Growth
-14.4%
Profit Margin
10.7%
ROE
0.0%
Debt / Equity
0.00
Beta
0.81
ValueDividend AristocratsBeaten Down

Statistics

Similar Stocks · Healthcare

Latest News · EMBC